This is crucial in remote communities, as a feasibility study of implementing new G6PD testing at health centres in 2021 suggested that only half of the eligible patients visited the health centres for G6PD testing after they were diagnosed with malaria by VMWs on the communities [30]. This evidence concerns the gene G6PD and malaria.